Success, Failure, and Transparency in Biomarker-Based Drug Development-Reference-Cited by-同舟云学术

Success, Failure, and Transparency in Biomarker-Based Drug Development

Published:2017-06 Issue:6 Volume:10 Page:
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ Cardiovasc Qual Outcomes

Author:

Hey Spencer Phillips¹,Franklin Jessica M.¹,Avorn Jerry¹,Kesselheim Aaron S.¹

Affiliation:

1. From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA (S.P.H., J.M.F., J.A., A.S.K.); and Harvard Center for Bioethics, Harvard Medical School, Boston, MA (S.P.H., A.S.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference80 articles.

1. Report to the President on propelling innovation in drug discovery, development, and evaluation.;The President’s Council of Advisors on Science and Technology;Executive Office of the President,2012

2. The Strength of Association Between Surrogate End Points and Survival in Oncology

3. Surrogate Outcomes in Clinical Trials

4. Countering imprecision in precision medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The comprehensive, customized, cost‐effective approach (CCCAP) to prevention of dementia;Alzheimer's & Dementia;2022-02

2. Gaining Efficiency in Clinical Trials With Cardiac Biomarkers;Journal of the American College of Cardiology;2021-04

3. Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes;JAMA Network Open;2019-04-12

4. Dementia: Paradigm shifting into high gear;Alzheimer's & Dementia;2019-04-09

5. Challenges and Opportunities for Biomarker Validation;Journal of Law, Medicine & Ethics;2019